The stock market was down yesterday and it is down again today. Bearish sentiment is roaming through Wall Street right now, so I thought I would look back on another occasion when the market was going through similar turmoil and I wrote about the following eight stocks, which I though
Senior banks will sign up for Belgian brewer InBev's $45 billion loan to finance its acquisition of rival Anheuser-Busch next week , but bank capital constraints have created a shortfall that could affect the syndication of up to $200 billion of recent M&A loans.
InBev asked banks to commit $1.75 billion each in return for high fees of 100 basis points (b.p.) or $17.5 billion and rich interest margins of 175 b.p., stepping down to 100 b.p.
Some banks found $1.75 billion challenging and made smaller commitments that were difficult for the arranging banks, which need ful
Anheuser-Busch Cos Inc on Tuesday said it approved an enhanced employee buyout program that it expects will reduce its salaried work force 10 percent to 15 percent.
The revised program will provide enhanced pension and retiree medical benefits, as well as severance, to salaried employees who are at least 55 years old as of December 31, 2008.
For eligible participants who are among a group of about 360 key employees, the severance benefit will range from 15 months of base salary to double the sum of base salary and a target bonus. It will also include continuation of medical benefits
TheStreet.com's Jim Cramer says the biotechs look sweet in a bank-led slowdown.
Thank you, New York Times. Remember just a couple of weeks ago, when The New York Times wrote about how Genentech's (NYSE: DNA) (Cramer's Take) Avastin was too expensive and the stock got cracked down to $77? I know Roche did. I bet that was the last draw. The dramatic decline in the dollar plus a sentiment that has spawn...
Analysts' Recommendation: Hold 30 Days Ago: Hold Analysts' Target: $58 Analysts' Targets HSBC Securities $65 Neutral Friday, June 13, 2008 Deutsche Bank Securities $56 Accumulate Friday, May 23, 2008 BWS Financial $54 Buy Monday, March 24, 2008 BWS Financial $54 Buy Monday, March 24, 2008 Credit Suisse $55 Hold Friday, February 01, 2008
Don't know where the market is headed? Some people think a full blown crash is possible; some believe this is a good time to buy while others just don't know what to believe. Well, I just don't care and neither should you.
Because if you're like me, you've learned to take everything one high percentage profit trade at a time, whether you're betting on higher or lower prices. That's right, I'm talking...
I love watching those old Andy Griffen shows Don Knotts. That man was a comedic genious. But nonbody ever gives him the credit he deserves. Why? Because he lived long enough to do Three's Company and what was that movie with him as a fish?
If Buffett would have died in 2003 he would have gone down in history as being the greatest investor to ever live.
But instead he lived long enough for the truth to come out.
A man thatinvest in gold will look smart during a gold rush. A man that invests in bio-medical looks like a genious during the craze 80s.
A trade-off of strong capital gain growth, its great dividend will keep people holding. Meanwhile, analyst estimates are showing modest earnings growth for a mature company trading at a P/E in the teens compared to other Consumer Staples KO, PG or and MCD trading way too high for a buy. If you're already holding, hang onto it.
Dividend payable to shareholders of record 02/11/2008. It'll continue up with its 4Q earnings release and a favorable outlook during a recession. Its even a good hold for the rest of the year, but I'll be closing the position at an undisclosed time after t
What's the big deal with beer that taste like horse pi** in a bottle are goat mature in a can. People are looking for something with a real beer taste and Companies like Pyramid Brewers and Sam's are coming through! Dang! even a Miller Lite puts a person three sheets in the wind when a Bud only make you pi** again.
Anheuser-Busch, indisputably the King of Beers, is about as safe of a bet in the brewing industry as one can find. They continue to aggressively market their products, increase profitability and pay a dividend which has risen steadily over the years. After the positive Q1 earnings release, with a profit margin of 9.3 percent, they could quite possibly beat analyst's expectations this year. Excellent play.
BUY: Anheuser-Busch Companies, Inc. (NYSE: BUD) $49.90 (5/11/07) Sell price: $52.40 or Sell date: June 11, 2007Stop loss: $48.55 (-2.7%) Stochastic very bullishStrong bullish 1 day moneyflowBouncing off very strong support at $49.89MACD trending bullish since May 1 Needs to beat key resistance at $51.20 Profile: Anheuser-Busch Companies, Inc. [...]
Please find our reading of the technicals of this chart and many, many others at our public listing at stockcharts.com. You may use the following link to access the same:
Is this BUD for you?
- Anheuser-Busch InBev plans to sell €6.36B ($8.05B) of stock to fund the transaction that formed the company. The sales was originally planned for las...
BUD Anheuser Busch
- From Free Trial: https://secure.valueinvestorinsight.com/freetrial/
Picks from VALUE INVESTOR INSIGHT show BUD was a value buy last year. I bought it
Data powered by QuoteMedia.
All Rights Reserved.
Data delayed 15 to 20 minutes unless otherwise indicated.
Terms of Use.
None of the information contained on SocialPicks.com constitutes a recommendation by SocialPicks or its users that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. SocialPicks is not responsible for the posts, discussions, and recommendations of the users on the Site. SocialPicks does not provide investment advice. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the website. SocialPicks' users' past results are not necessarily indicative of future performance. Neither SocialPicks nor any of its users guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the website. You understand and agree that you use the Site and Services at your own discretion and risk and that you will be solely responsible for any damages that arise from such use. Before acting on any information contained on the website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.